hepatitis
Asia-Pacific Nations Prodded On Hepatitis Action Plans
Experts say that the Asia-Pacific region needs more cross-sector partnerships and funding to tackle viral hepatitis.
WHO Issues First Hepatitis C Guidelines
The recommendations include increasing hepatitis C screening, liver damage mitigation and how to select appropriate treatment for chronic infections.
Cost Effective To Track Hepatitis B Carriers
A study has determined that monitoring inactive chronic hepatitis B carriers is a cost-effective strategy for managing the disease in China.
Kunshan RiboQuark Receives Series A Funding For QPI-1007
Kunshan RiboQuark Pharmaceutical Technology has raised nearly RMB 45 million in a series A financing round to accelerate the clinical development of QPI-1007.
Antiviral Therapy For Hep C Improved Diabetes Outcomes
Research from Taiwan has shown that antiviral therapy for hepatitis C virus improved kidney and cardiovascular outcomes for patients with diabetes.
Men-Only Hepatitis B Mutation Explains Higher Cancer Rates
A mutation in the hepatitis B virus (HBV) that appears only in men could explain why HBV-infected men have much higher liver cancer rates.
WHO Urges Action On Hepatitis Threat
The World Health Organization has urged governments to act against the five hepatitis viruses that can cause severe liver infections.
Exosomes Transmit Cell-To-Cell Antiviral Resistance, Study
Researchers in China have discovered a mechanism by which mice prevent the viral destruction of the host immune system.
BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China
BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.
